Participants should be given feedback about the trial

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7024.186a (Published 20 January 1996) Cite this as: BMJ 1996;312:186
  1. Sally Marshall
  1. Clinical metrologist Rheumatology Department, Mount Gould Hospital, Plymouth PL4 7QD

    EDITOR,—Elizabeth Wager and colleagues have set out extremely useful guidelines for gaining patients' consent to enter clinical trials.1 I have undertaken an anonymous, retrospective postal survey of 90 patients who participated in five trials of treatment for rheumatoid arthritis and one for ankylosing spondylitis. Seventy patients returned questionnaires (78% response rate). Most (69) thought that they had received a full explanation of the study and (67) that they had not been put under any pressure to take part, and all …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription